Janssen ’ s respiratory panel wins 510(k) clearance

Johnson & Johnson (NYSE:JNJ) subsidiary Janssen Diagnostics said today that it won 510(k) clearance from the FDA for its Idylla respiratory panel. The diagnostic test, developed in partnership with Biocartis Group, helps physicians identify viral respiratory infections, including infection from respiratory syncytial virus and influenza virus. Get the full story at our sister site, Drug Delivery Business News. The post Janssen’s respiratory panel wins 510(k) clearance appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Wall Street Beat janssendiagnostics johnsonandjohnson Source Type: news